A Prospective, Randomized, Controlled, Single-center Phase II Clinical Trial of Trilaciclib Combined With Concurrent Chemoradiotherapy and Immunotherapy for Locally Advanced Esophageal Cancer
Latest Information Update: 28 Aug 2024
At a glance
- Drugs Trilaciclib (Primary) ; Carboplatin; Nedaplatin; Paclitaxel
- Indications Oesophageal cancer; Squamous cell cancer
- Focus Therapeutic Use
Most Recent Events
- 28 Aug 2024 New trial record